6.
Zeng Q, Li S, Chepeha D, Giordano T, Li J, Zhang H
. Crosstalk between tumor and endothelial cells promotes tumor angiogenesis by MAPK activation of Notch signaling. Cancer Cell. 2005; 8(1):13-23.
DOI: 10.1016/j.ccr.2005.06.004.
View
7.
Rehman A, Wang C
. Notch signaling in the regulation of tumor angiogenesis. Trends Cell Biol. 2006; 16(6):293-300.
DOI: 10.1016/j.tcb.2006.04.003.
View
8.
van der Woude L, Gorris M, Halilovic A, Figdor C, de Vries I
. Migrating into the Tumor: a Roadmap for T Cells. Trends Cancer. 2017; 3(11):797-808.
DOI: 10.1016/j.trecan.2017.09.006.
View
9.
Thommen D, Schumacher T
. T Cell Dysfunction in Cancer. Cancer Cell. 2018; 33(4):547-562.
PMC: 7116508.
DOI: 10.1016/j.ccell.2018.03.012.
View
10.
Ozdemir B, Pentcheva-Hoang T, Carstens J, Zheng X, Wu C, Simpson T
. Depletion of carcinoma-associated fibroblasts and fibrosis induces immunosuppression and accelerates pancreas cancer with reduced survival. Cancer Cell. 2014; 25(6):719-34.
PMC: 4180632.
DOI: 10.1016/j.ccr.2014.04.005.
View
11.
Mucciolo G, Araos Henriquez J, Jihad M, Pinto Teles S, Manansala J, Li W
. EGFR-activated myofibroblasts promote metastasis of pancreatic cancer. Cancer Cell. 2023; 42(1):101-118.e11.
DOI: 10.1016/j.ccell.2023.12.002.
View
12.
Biffi G, Oni T, Spielman B, Hao Y, Elyada E, Park Y
. IL1-Induced JAK/STAT Signaling Is Antagonized by TGFβ to Shape CAF Heterogeneity in Pancreatic Ductal Adenocarcinoma. Cancer Discov. 2018; 9(2):282-301.
PMC: 6368881.
DOI: 10.1158/2159-8290.CD-18-0710.
View
13.
Zhu Y, Knolhoff B, Meyer M, Nywening T, West B, Luo J
. CSF1/CSF1R blockade reprograms tumor-infiltrating macrophages and improves response to T-cell checkpoint immunotherapy in pancreatic cancer models. Cancer Res. 2014; 74(18):5057-69.
PMC: 4182950.
DOI: 10.1158/0008-5472.CAN-13-3723.
View
14.
Karin N
. Chemokines and cancer: new immune checkpoints for cancer therapy. Curr Opin Immunol. 2018; 51:140-145.
DOI: 10.1016/j.coi.2018.03.004.
View
15.
Zhang L, Conejo-Garcia J, Katsaros D, Gimotty P, Massobrio M, Regnani G
. Intratumoral T cells, recurrence, and survival in epithelial ovarian cancer. N Engl J Med. 2003; 348(3):203-13.
DOI: 10.1056/NEJMoa020177.
View
16.
Galon J, Costes A, Sanchez-Cabo F, Kirilovsky A, Mlecnik B, Lagorce-Pages C
. Type, density, and location of immune cells within human colorectal tumors predict clinical outcome. Science. 2006; 313(5795):1960-4.
DOI: 10.1126/science.1129139.
View
17.
Ohlund D, Handly-Santana A, Biffi G, Elyada E, Almeida A, Ponz-Sarvise M
. Distinct populations of inflammatory fibroblasts and myofibroblasts in pancreatic cancer. J Exp Med. 2017; 214(3):579-596.
PMC: 5339682.
DOI: 10.1084/jem.20162024.
View
18.
Adams R
. Molecular control of arterial-venous blood vessel identity. J Anat. 2003; 202(1):105-12.
PMC: 1571062.
DOI: 10.1046/j.1469-7580.2003.00137.x.
View
19.
Hingorani S, Wang L, Multani A, Combs C, Deramaudt T, Hruban R
. Trp53R172H and KrasG12D cooperate to promote chromosomal instability and widely metastatic pancreatic ductal adenocarcinoma in mice. Cancer Cell. 2005; 7(5):469-83.
DOI: 10.1016/j.ccr.2005.04.023.
View
20.
Tan W, Zhang W, Strasner A, Grivennikov S, Cheng J, Hoffman R
. Tumour-infiltrating regulatory T cells stimulate mammary cancer metastasis through RANKL-RANK signalling. Nature. 2011; 470(7335):548-53.
PMC: 3166217.
DOI: 10.1038/nature09707.
View